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In old rats, cardiac frequency exhibited higher values than in
control. Coronary flow was variable in time in aging rats in com-
parison with young ones where a slow decrease was observed during
the experiment. Pressure developed by the left ventricle was net
elevated in aging rats but with fluctuations in time. No internucle-
osomal fragmentation and DNA laddering displaying has been
observed for this experimental model. Our electron microscopy
studies have pointed out greater damage in old hearts in terms of
myofiber tears, mitochondrial and sarcoplasmic reticulum disruption.
Our data have pointed out that aging rat heart has an increased
reactivity towards stress conditions imposed by ischemia–reperfusion.
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Insights for the release of phosphate by myosin motors
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2University of Pennsylvania, School of Medicine, Department of
Physiology, Philadelphia, PA, USA *These co-authors have
contributed equally to this work.
Force production in myosin motors is tightly coupled to transitions
promoted by actin binding that allow release of phosphate followed
by release of ADP. While the release of phosphate is the rate limiting
step for conventional muscle myosin II, it is much faster for several
unconventional myosins. Coupling structural and kinetic studies for
different myosins has shown that they populate similar structural
states. These studies have elucidated how certain transitions of the
actin-myosin catalytic cycle, including the ATP-induced dissociation
of myosin from actin and for the ATP hydrolysis step that allows
priming of the lever arm. Not yet visualized however are the struc-
tural rearrangements triggered by actin binding that are coupled to
force generation and product release.
While phosphate is produced in the pre-powerstroke (ADP.Pi)
state, it is also trapped in this state until an actin-activated transition
opens a back-door to promote its release from the active site. It is
unclear, however, which of the three elements of the active site
(Switch I, Switch II and the P-loop) play a role in this transition and
whether the major cleft within the motor partially closes to allow this
release while keeping the lever arm primed.
We have crystallized a new structural state for myosin VI in the
presence of MgADP and phosphate that has an open back-door due to
a Switch II rearrangement and a lever arm primed. Thus it has the
expected features of the previously unseen Pi release state of myosin.
Kinetic and structural studies on a number of mutants from different
myosins are currently being performed to evaluate this possibility.
The structure is consistent with cleft closure occurring subsequent to
Pi release, which is also being tested. An interesting finding in this
new structure is that the SH1 helix kinks to allow the converter to stay
in the primed position, the signature of a state at the beginning of
force production.
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Structural properties of actin-myosin complexes in contracting
rabbit muscle fibres subjected to stretch or producing
mechanical work
A.K. Tsaturyan1, N.A. Koubassova1, S.Y. Bershitsky2,
M. Fernandez3, O. Narayanan3, M.A. Ferenczi4
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Low angle time-resolved x-ray diffraction (beamline ID02, ESRF,
Grenoble, France) was used to study structural properties of cross-
bridges in permeabilized fibres of rabbit skeletal muscle at full
activation at near physiological temperature of 31–34 C.
Bundles of 2–3 fibres were stretched at a constant velocity of
1–1.2 length/s or allowed to shorten at a load of ca. P0/3 or 2P0/3
where P0 is isometric tension. Two 10–30 ms long x-ray frames were
taken in each run of a protocol: during isometric contraction and at
the end of the ramp stretch or shortening. The two 2D x-ray dif-
fraction patterns were compared. Changes in fibre stiffness were
measures in control experiments.
Stretch induced a decrease in the meridional M3 intensity and in
the off-meridional intensities of M1, M2 myosin and A1, A2 actin
layer lines and to a *30 % increase in stiffness. The data indicate
that stretch unlocks stereo-specifically bound myosin heads and
promotes non-stereo-specific binding to actin of detached myosin
explaining high stiffness and low ATPase rate of contracting muscle
during stretch. Shortening decreases stiffness, the intensities of M3,
actin layer lines and of the AM+1 actin-myosin layer line at
*10.3 nm. The intensity decrease was very small during slow
shortening and more pronounced under load below 0.4P0.
The data show that three processes: ‘roll and lock’ transition of
actin-myosin complexes, tilt of the myosin lever arm and the rate of
detachment of strongly bound myosin heads have different strain-
dependence.
Supported by the Royal Society, EMBL, RFBR and RAS.
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Modified EC coupling in myostatin deficient (MSTN2/2) mice
A. Jenes1, D. Bodnár1, O. Ruzsnavszky1, N. Geyer1, B. Dienes1,
A. Balogh2, Z. Papp2, P. Szentesi1, L. Csernoch1
1University of Debrecen, Medical and Health Science Center,
Department of Physiology, Debrecen, Hungary; 2University of
Debrecen, Medical and Health Science Center, Department of
Cardiology, Debrecen, Hungary
Myostatin, a member of the transforming growth factor b superfamily
has emerged as a potent negative regulator of skeletal muscle growth.
During embryogenesis, myostatin influences the differentiation and
proliferation of myoblasts. MSTN-/- mice have increased muscle
mass demonstrating that myostatin is a negative regulator of skeletal
muscle development. Excessive muscle mass in MSTN-/- mice is
associated with a profound loss of oxidative metabolic properties.
In our studies we compared MSTN-/- and control C57/BL6 mice.
We investigated the muscle performance during moderate intensity
voluntary wheel running and in grip tests. We measured force and
fatigue of musculus soleus (SOL) and extensor digitorum longus (EDL).
Isometric force measurements were performed during repeated acti-
vation–relaxation cycles. pCa-force relations were determined to assess
the Ca2+-sensitivity of force production. Changes in intracellular Ca2+
concentration were measured in single fibers.
In voluntary wheel running MSTN-/- mice performed better on
average (10.8 ± 0.8 versus 7.9 ± 1.0 m/min), in maximal speed
(25.4 ± 1.3 versus 16.8 ± 1.3 m/min), and in total distance
(7.50 ± 0.88 versus 5.57 ± 0.53 km/day), but they spent less time in
the wheel (585 ± 59 versus 622 ± 40 min/day). In grip tests
MSTN-/- mice showed higher average force (0.24 ± 0.01 versus
0.13 ± 0.01 mN). Single twitches in EDL (102.8 ± 30.0 vs
84.5 ± 43.9 mN) and SOL (138.3 ± 45.7 vs 49.1 ± 24.8 mN) were
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stronger in the control strain. pCa-force relations and calcium-
transients evoked by KCl depolarization did not differ. Resting
intracellular calcium concentrations were significantly elevated in
MSTN-/- mice (464 ± 159 versus 573 ± 123 nM).
Our results from in vitro experiments do not explain our in vivo
findings.
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Altered cross bridge kinetics in skeletal myofibrils from neb
DEX55, a novel mouse model of nebulin-based nemaline myopathy
C. Ferrara1, C. Buck2, N. Piroddi1, C. Tesi1, J. LeWinter3,
C. Ottenheijm2,3, C. Poggesi1, H. Granzier3
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Nemaline Myopathy is the most common non-dystrophic congenital
myopathy, clinically characterized by muscle weakness. The disease
is most often associated with mutations in the nebulin gene and the
nebulin-based disease is referred to as NEM2. Recent work on
skinned muscle fibres from NEM2 patients revealed remarkable
phenotypic similarities to fibres from nebulin KO mice (Ottenheijm
et al. Frontiers in Physiology, 2012). Here we investigated mechanics
and kinetics of single myofibrils from a novel NEM2 mouse model
(NEB Dex55) that mimics a deletion in the nebulin gene found in a
large group of NEM2 patients.
We used rapid solution switching (Tesi et al., Biophys. J., 2002) to
compare maximal tension and kinetics of contraction and relaxation
of myofibrils isolated from frozen skeletal muscles (tibialis cranialis
of neonatal mice, *7 days) of WT and NEB Dex55 mice. Myofibrils,
mounted in a force recording apparatus (15 C), were maximally
Ca2+-activated (pCa 4.5) and fully relaxed (pCa 9.0).
Maximal isometric tension was markedly reduced in NEB Dex55
mouse myofibrils (49.7 ± 10.6 mN mm-2 n = 11) compared to WT
(135.3 ± 16.9 mN mm-2 n = 9). The rate constant of active tension
generation following maximal Ca2+ activation (kACT) was signifi-
cantly reduced in myofibrils from the NEB Dex55 mouse model
(1.46 ± 0.07 s-1) compared to WT (2.75 ± 0.27 s-1). Force relax-
ation kinetics upon Ca2+ removal were remarkably faster in NEB
Dex55 mouse myofibrils than in WT, evidence that the apparent rate
with which cross-bridges leave the force generating states is accel-
erated in the NEB Dex55sarcomeres.
Reduction in the rate with which cross-bridges enter the force
generating state and increase in the rate of cross bridge dissociation
can markedly contribute to reducing maximal tension and are
expected to increase the energetic cost of tension generation of the
NEB Dex55sarcomeres. The results suggest that nebulin plays a
significant role in contraction regulation and that altered cross bridge
kinetics contribute to NEM2 pathogenesis.
82
p42/44 MAPK signaling mediates MYPT1 isoform expression
N.J. Brozovich, G.P. Hawes, S. Yuen, O. Ogut, F.V. Brozovich
Mayo Medical School, Cardiovascular Diseases, Rochester,
MN 55902 USA
During NO mediated vasodilatation PKG activates myosin light chain
(MLC) phosphatase, which dephosphorylates the MLC to produce
smooth muscle relaxation. MLC phosphatase is a trimeric enzyme
consisting of a catalytic, myosin targeting (MYPT1) and 20 kDa
subunits. Alternative mRNA splicing produces four MYPT1 isoforms,
which differ by the presence or absence of central insert (CI) and a
carboxy-terminal luecine zipper (LZ). PKG mediated activation of
MLC phosphatase requires the expression of a LZ+ MYPT1 isoform,
and thus, the sensitivity to NO mediated vasodilatation is mediated, in
part, by LZ+/LZ- MYPT1 expression. We have reported that during
heart failure, the increase in AngII is associated with an activation of
p42/44 MAPK signaling and a decrease in LZ+ MYPT1 expression.
The mechanism for angiotensin induced regulation of
LZ+ MYPT1 expression was assessed in cultured vascular smooth
muscle cells (SMCs). For these experiments, LZ+ MYPT1 expression
was determined in cultured SMCs at 24 h, 48 h and 72 h after Ang II
treatment (1 lM) and compared to the control of time in culture
alone. To investigate if the activation of p42/44 MAPK mediates the
AngII induced decrease in LZ+ MYPT1 expression, cultured SMCs
were stimulated with AngII in SMCs pretreated with a MEK inhibitor
(20 lM PD98059), and the time course of p42/44 MAPK activation
as well as LZ+ MYPT1 expression was determined.
AngII resulted in a time dependent activation of p42/44 MAPK.
Compared to control SMCs, SMCs treated with AngII had a signifi-
cant decrease in LZ+ MYPT1 expression. However pretreatment of
the SMCs with a MEK inhibitor (PD98059) blocked the AngII
induced activation of p42/44 MAPK and decrease of LZ+ MYPT1
expression.
These results demonstrate that LZ+ MYPT1 expression is regu-
lated by a p42/44 MAPK signaling pathway. During heart failure,
treatment with either ACE inhibitors or AngII receptor blockers will
prevent the activation of p42/44 MAPK and the resulting decrease in
LZ+ MYPT1 expression to preserve the sensitivity of vascular
smooth muscle to NO mediated vasodilatation.
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The super relaxed state in diverse muscle types
E. Pate1, N. Naber2, R. Cooke2
1Washington State University, Dept of Bioengineering, Pullman WA,
USA; 2University of California, Dept of Biochemistry, San Francisco,
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Recently, we observed a new state of skeletal myosin, the super
relaxed state (SRX), with a very slow ATP turnover rate. Inhibition of
the myosin ATPase activity in the SRX was suggested to be caused by
the binding of the myosin head to the core of the thick filament in a
structural motif identified earlier by electron microscopy.
The SRX also occurs in cardiac muscle. In both skeletal and
cardiac muscle the SRX appears to play a similar role in relaxed
cells, providing a state with a very low metabolic rate. However, in
active muscle the properties of the SRX differ dramatically. We
observed a rapid transition of myosin heads out of the SRX in active
skeletal fibers, while the population of the SRX remained constant in
active cardiac cells. This property allows the SRX to play a very
different role in cardiac muscle, regulating the active force generated
by cross-bridges and implying that at the level of the actomyosin
interaction, cardiac muscle is regulated at both the thick- and thin-
filament levels.
We have recently extended our approach to tarantula leg muscle.
We find a SRX, with a very slow nucleotide turnover time constant,
*30 min. Similar to cardiac muscle, myosin in tarantula fibers can
remain in the SRX upon activation, suggesting a role in the regulation
of active force. The fact that two such evolutionarily distant muscles,
vertebrate cardiac and arachnid exoskeletal, both display thick-
filament regulation of active force involving the SRX suggests this
mechanism of regulation can be anticipated to be widely distributed
among muscle types.
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